Failure of indomethacin to reduce hydroxyproline excretion or hypercalcemia in patients with breast cancer
- 1 December 1976
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 12 (6), 1027-1035
- https://doi.org/10.1016/0090-6980(76)90136-2
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Early morning hydroxyproline excretion in patients with breast cancerCancer, 1976
- BENIGN BREAST LESIONS AND OSTEOLYSISThe Lancet, 1976
- Prostaglandins as Mediators of Hypercalcemia Associated with Certain Types of CancerNew England Journal of Medicine, 1975
- BREAST CANCER, PROSTAGLANDINS, AND BONE METASTASESThe Lancet, 1975
- Hydroxyproline excretion in patients with breast cancer and response to treatment.BMJ, 1975
- Indomethacin-Responsive Hypercalcemia in a Patient with Renal-Cell AdenocarcinomaNew England Journal of Medicine, 1974
- The Inhibition by Aspirin and Indomethacin of Osteolytic Tumour Deposits and Hypercalcaemia in Rats with Walker Tumour, and its Possible Application to Human Breast CancerBritish Journal of Cancer, 1973
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971
- Prostaglandins: Stimulation of Bone Resorption in Tissue CultureEndocrinology, 1970
- A specific method for the analysis of hydroxyproline in tissues and urineAnalytical Biochemistry, 1960